Apriem Advisors’s Bio-Techne TECH Stock Holding History

Apriem Advisors’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-112	Closed	-$3K	–	493
2017 Q1	$3K	Hold	112	–	–	﹤0.01%	565
2016 Q4	$3K	Hold	112	–	–	﹤0.01%	594
2016 Q3	$3K	Buy	+112	New	+$3.08K	﹤0.01%	518

Other funds holding TECH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Apriem Advisors's TECH Position: Q2 2017 in Review

Apriem Advisors sold out of Bio-Techne (TECH) in Q2 2017, closing a stake of 112 shares — an estimated $3K sold.

Apriem Advisors first reported a position in TECH in Q3 2016 and held it in 3 quarters. The position peaked at $3K in Q1 2017. 280 funds tracked by Wall St. Rank hold TECH as of Q2 2017.

Apriem Advisors reported no remaining Bio-Techne position as of Q2 2017 after selling out during the quarter.
Apriem Advisors sold 112 Bio-Techne shares in Q2 2017, an estimated $3K.
Apriem Advisors first reported a position in Bio-Techne in Q3 2016 and held it in 3 quarters.
Apriem Advisors's Bio-Techne position peaked at $3K in Q1 2017.
280 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2017.

Based on Apriem Advisors's 13F filing for Q2 2017, filed 4 Aug 2017.